No Data
Acurx Pharmaceuticals Says Selling Shareholders May Sell 2.6 Million Shares
H.C. Wainwright Reaffirms Their Buy Rating on Acurx Pharmaceuticals (ACXP)
Promising Developments and Regulatory Milestones Justify Buy Rating for Acurx Pharmaceuticals
Insider Purchase: Director at $ACXP (ACXP) Buys 24,631 Shares
Express News | Acurx Pharmaceuticals CEO David Luci Reported Purchase Of 98,522 Shares @ Avg Price Of $0.51/Share In Form 4 Filing
Acurx Launches $2.5 Million Registered Direct Offering; Shares Fall After-Hours
Hatt piche hatt OP : BULLISH